Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.

Markus Schneider; Arnfried U Klingbeil; Christian Delles; Malte Ludwig; Rainer E Kolloch; Michael Krekler; Klaus O Stumpe; Roland E Schmieder

doi:10.1161/01.HYP.0000133249.28773.d7

Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.

Markus Schneider, Arnfried U Klingbeil, Christian Delles, Malte Ludwig, Rainer E Kolloch, Michael Krekler, Klaus O Stumpe, Roland E Schmieder

Department of Internal Medicine IV, Division of Nephrology and Hypertensiology

Research output: Contribution to journal › Original Article › peer-review

47 Citations (Web of Science)

Original language	English
Pages (from-to)	61-66
Journal	HYPERTENSION
Volume	44
Issue number	1
DOIs	https://doi.org/10.1161/01.HYP.0000133249.28773.d7
Publication status	Published - 2004

Keywords

ESSENTIAL-HYPERTENSION
CARDIOVASCULAR RISK
ELECTROCARDIOGRAPHIC DETECTION
PROGNOSTIC IMPLICATIONS
HYPERTROPHY
METAANALYSIS
REGRESSION
VALIDATION
REDUCTION
CRITERIA

Access to Document

10.1161/01.HYP.0000133249.28773.d7

Cite this

Schneider, M., Klingbeil, A. U., Delles, C., Ludwig, M., Kolloch, R. E., Krekler, M., Stumpe, K. O., & Schmieder, R. E. (2004). Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. HYPERTENSION , 44(1), 61-66. https://doi.org/10.1161/01.HYP.0000133249.28773.d7

Schneider, Markus ; Klingbeil, Arnfried U ; Delles, Christian et al. / Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. In: HYPERTENSION 2004 ; Vol. 44, No. 1. pp. 61-66.

@article{bf3cabc852cf4021a91f8ad6c71240eb,

title = "Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.",

keywords = "ESSENTIAL-HYPERTENSION, CARDIOVASCULAR RISK, ELECTROCARDIOGRAPHIC DETECTION, PROGNOSTIC IMPLICATIONS, HYPERTROPHY, METAANALYSIS, REGRESSION, VALIDATION, REDUCTION, CRITERIA",

author = "Markus Schneider and Klingbeil, {Arnfried U} and Christian Delles and Malte Ludwig and Kolloch, {Rainer E} and Michael Krekler and Stumpe, {Klaus O} and Schmieder, {Roland E}",

year = "2004",

doi = "10.1161/01.HYP.0000133249.28773.d7",

language = "English",

volume = "44",

pages = "61--66",

journal = "HYPERTENSION ",

issn = "0194-911X",

number = "1",

}

Schneider, M, Klingbeil, AU, Delles, C, Ludwig, M, Kolloch, RE, Krekler, M, Stumpe, KO & Schmieder, RE 2004, 'Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.', HYPERTENSION , vol. 44, no. 1, pp. 61-66. https://doi.org/10.1161/01.HYP.0000133249.28773.d7

Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. / Schneider, Markus; Klingbeil, Arnfried U; Delles, Christian et al.
In: HYPERTENSION , Vol. 44, No. 1, 2004, p. 61-66.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.

AU - Schneider, Markus

AU - Klingbeil, Arnfried U

AU - Delles, Christian

AU - Ludwig, Malte

AU - Kolloch, Rainer E

AU - Krekler, Michael

AU - Stumpe, Klaus O

AU - Schmieder, Roland E

PY - 2004

Y1 - 2004

KW - ESSENTIAL-HYPERTENSION

KW - CARDIOVASCULAR RISK

KW - ELECTROCARDIOGRAPHIC DETECTION

KW - PROGNOSTIC IMPLICATIONS

KW - HYPERTROPHY

KW - METAANALYSIS

KW - REGRESSION

KW - VALIDATION

KW - REDUCTION

KW - CRITERIA

U2 - 10.1161/01.HYP.0000133249.28773.d7

DO - 10.1161/01.HYP.0000133249.28773.d7

M3 - Original Article

C2 - 15184349

SN - 0194-911X

VL - 44

SP - 61

EP - 66

JO - HYPERTENSION

JF - HYPERTENSION

IS - 1

ER -

Schneider M, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M et al. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project. HYPERTENSION . 2004;44(1):61-66. doi: 10.1161/01.HYP.0000133249.28773.d7